Acid Reducer
NDC Package 49348-026-54
Package Information
Acid Reducer is ranitidine is known as an H2 blocker. Marketed by Mckesson, this product is identified by NDC 49348-026 and is authorized under FDA application ANDA200536.
Identification & Billing
- RxCUI: 198191 - ranitidine 150 MG Oral Tablet
- RxCUI: 198191 - ranitidine 150 MG (as ranitidine HCl 168 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49348 - Mckesson
- 49348-026 - Acid Reducer
- 49348-026-54 - 1 BOTTLE in 1 CARTON / 65 TABLET in 1 BOTTLE
- 49348-026 - Acid Reducer
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49348-026). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49348-026-54 identifies a specific commercial package of 1 bottle in 1 carton / 65 tablet in 1 bottle of Acid Reducer, labeled by Mckesson. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson on January 07, 2014. The current certification is valid through December 31, 2019.
What are the primary indications for this medication?
Ranitidine is known as an H2 blocker. It works by reducing the amount of acid in your stomach. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.
How is this Mckesson product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49348002654. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.